Article Versions Notes

Alsuhibani AA, Alobaid NA, Alahmadi MH, Alqannas JS, Alfreaj WS, Albadrani RF, Alamer KA, Almogbel YS, Alhomaidan A, Guo JJ. Antifungal Agents’ Trends of Utilization, Spending, and Prices in the US Medicaid Programs: 2009–2023. Antibiotics. 2025; 14(5):518. https://doi.org/10.3390/antibiotics14050518

Alsuhibani, Abdulrahman A., Norah A. Alobaid, Manar H. Alahmadi, Jood S. Alqannas, Wejdan S. Alfreaj, Rana F. Albadrani, Khalid A. Alamer, Yasser S. Almogbel, Ali Alhomaidan, and Jeff J. Guo. 2025. "Antifungal Agents’ Trends of Utilization, Spending, and Prices in the US Medicaid Programs: 2009–2023" Antibiotics 14, no. 5: 518. https://doi.org/10.3390/antibiotics14050518

Alsuhibani, A. A., Alobaid, N. A., Alahmadi, M. H., Alqannas, J. S., Alfreaj, W. S., Albadrani, R. F., Alamer, K. A., Almogbel, Y. S., Alhomaidan, A., & Guo, J. J. (2025). Antifungal Agents’ Trends of Utilization, Spending, and Prices in the US Medicaid Programs: 2009–2023. Antibiotics, 14(5), 518. https://doi.org/10.3390/antibiotics14050518